IP Library Granted Patent US 7,267,665
Granted Patent B2
US 7,267,665 · App. 10/335,275 · Granted Sep 11, 2007

Closed loop system for controlling insulin infusion

Assignee: Medtronic MiniMed, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,267,665
App. No.
10/335,275
Granted
Sep 11, 2007
Kind
B2
Abstract

A closed loop infusion system controls the rate that fluid is infused into the body of a user. The closed loop infusion system includes a sensor system, a controller, and a delivery system. The sensor system includes a sensor for monitoring a condition of the user. The sensor produces a sensor signal, which is representative of the condition of the user. The sensor signal is used to generate a controller input. The controller uses the controller input to generate commands to operate the delivery system. The delivery system infuses a liquid into the user at a rate dictated by the commands from the controller. Preferably, the sensor system monitors the glucose concentration in the body of the user, and the liquid infused by the delivery system into the body of the user includes insulin.

Claims (18)

1. A method of infusing insulin into a body of a user, the method comprising:

obtaining a blood glucose concentration of the user;

generating a controller input based on the blood glucose concentration; and

generating infusion commands by a proportional plus, integral plus, derivative (PID) controller from the controller input using at least one preset controller gain;

wherein the at least one preset controller gain includes at least one tuning parameter that further modifies the infusion commands generated by the PID controller to create an insulin concentration profile that more closely resembles the insulin concentration profile that would be generated by the release of insulin by beta cells in an individual with a healthy normally functioning pancreas; and

wherein the at least one tuning parameter is an integrator leak.

2. A method of infusing insulin into a body of a user, the method comprising:

obtaining a blood glucose concentration of the user;

generating a controller input based on the blood glucose concentration; and

generating infusion commands by a proportional plus, integral plus, derivative (PID) controller from the controller input using at least one preset controller gain;

wherein the at least one preset controller gain includes at least one tuning parameter that further modifies the infusion commands generated by the PID controller to create an insulin concentration profile that more closely resembles the insulin concentration profile that would be generated by the release of insulin by beta cells in an individual with a healthy normally functioning pancreas; and

wherein the at least one tuning parameter is a lead/lag compensator.

3. A method of infUsing insulin into a body of a user, the method comprising:

obtaining a blood glucose concentration of the user;

generating a controller input based on the blood glucose concentration; and

generating infusion commands by a proportional plus, integral plus, derivative (PID) controller from the controller input using at least one preset controller gain;

wherein the at least one preset controller gain includes at least one tuning parameter that further modifies the infUsion commands generated by the PID controller to create an insulin concentration profile that more closely resembles the insulin concentration profile that would be generated by the release of insulin by beta cells in an individual with a healthy normally functioning pancreas; and

wherein the at least one tuning parameter is an integrator clip.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 17, 2003
From: STEIL, GARRY M.; REBRIN, KERSTIN
To: MEDTRONIC MINIMED, INC.
Reel/Frame 013847/0700 →
Continuity (4)
Continuation In Part 0958617500 · Jun 1, 2000
Provisional Application 6016225500 · Oct 29, 1999
Provisional Application 6013760100 · Jun 3, 1999
Related Publication 20030130616A1 · Jul 10, 2003